Nexien BioPharma, Inc.Nexien BioPharma, Inc.Nexien BioPharma, Inc.

Nexien BioPharma, Inc.

No trades
See on Supercharts
Market capitalization
‪1.36 M‬USD
−0.0043USD
‪−361.90 K‬USD
‪30.97 M‬
Beta (1Y)
−0.57

About Nexien BioPharma, Inc.

CEO
Richard Greenberg
Headquarters
Glendale
Founded
1952
FIGI
BBG000H79V16
Nexien BioPharma, Inc. engages in the development and commercialization of Food and Drug Administration-compliant cannabinoid pharmaceuticals, drug delivery systems, and related technologies for diseases, disorders, and medical conditions. Its flagship research and development programs are focused on advancing formulations to significantly improve the treatment outcomes of certain convulsive disorders and neuromuscular disorders. The company was founded by Richard Greenberg on November 10, 1952 and is headquartered in Glendale, CO.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of NXEN is 0.0227 USD — it has increased by 12.63% in the past 24 hours. Watch Nexien BioPharma, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Nexien BioPharma, Inc. stocks are traded under the ticker NXEN.
NXEN stock is 38.96% volatile and has beta coefficient of −0.57. Track Nexien BioPharma, Inc. stock price on the chart and check out the list of the most volatile stocks — is Nexien BioPharma, Inc. there?
Yes, you can track Nexien BioPharma, Inc. financials in yearly and quarterly reports right on TradingView.
NXEN stock has fallen by 21.90% compared to the previous week, the month change is a 8.27% rise, over the last year Nexien BioPharma, Inc. has showed a 6.02% decrease.
NXEN net income for the last quarter is ‪−24.52 K‬ USD, while the quarter before that showed ‪−74.92 K‬ USD of net income which accounts for 67.27% change. Track more Nexien BioPharma, Inc. financial stats to get the full picture.
Today Nexien BioPharma, Inc. has the market capitalization of ‪1.36 M‬, it has decreased by 2.34% over the last week.
No, NXEN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, NXEN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Nexien BioPharma, Inc. stock right from TradingView charts — choose your broker and connect to your account.
NXEN reached its all-time high on Oct 11, 1989 with the price of 1151.7696 USD, and its all-time low was 0.000006 USD and was reached on Mar 2, 2015. View more price dynamics on NXEN chart.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Nexien BioPharma, Inc. technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Nexien BioPharma, Inc. stock shows the sell signal. See more of Nexien BioPharma, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.